zileuton has been researched along with Libman-Sacks Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandwein, SR; Hackshaw, KV; Jones, K; Shi, Y; Westcott, JY | 1 |
1 trial(s) available for zileuton and Libman-Sacks Disease
| Article | Year |
|---|---|
A pilot study of zileuton, a novel selective 5-lipoxygenase inhibitor, in patients with systemic lupus erythematosus.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Hydroxyurea; Leukotriene Antagonists; Leukotriene E4; Lipoxygenase Inhibitors; Lupus Erythematosus, Systemic; Male; Middle Aged; Pilot Projects; Prospective Studies; Treatment Outcome | 1995 |